exam 1 Flashcards
healthy people 2030 social determinates of health
economic stability
education access and quality
healthcare access and quality
neighborhood and built environment
social and community context
pathophysiology
study of the bodys response to dysfunction or disease
disease
an interruption, cessation, or disorder of a body system or organ structure
aspects of disease process
etiology, pathogenesis, morphologic changes, clinical manifestations, diagnosis, clinical course
etiologic factors
causes of disease/risk factors
biological agents (bacteria viruses)
physical forces (trauma, burns)
chemical agents (poison, alcohol)
nutritional excesses or deficits
etiolgic risk factors
congenital conditions- genetics, environmental(maternal drug use)
acquired defects- infection, injury, hypoxia, inappropriate immune responses
Pathogenesis
sequences of cellular and tissue events that take place from time of intial contact with etiologic agent until expression of disease
morphology
fundamental stucture or form of cells or tissues
histology
study if cells of body tissues
lesion: pathologic or traumatic discontinuity of a body organ or tissue
clinical manifestations
signs (objective) and symptoms (subjective)
syndrome
compilations of signs and symptoms
sequalae
lesions or impairments that follow or are caused by disease
complications
adverse extensions of disease or outcomes of treatment
diagnosis
designation as to the cause of the health problem… interpretation of diagnostic test results (CT, x-ray, labs, biopsy)
specificity
the proportion of people without the disease who are negative (true negative)
sensitivity
people with disease who are postive (true postive)
reliability
the extent to which an observation, when repeated, gives the same result
validity
the extent to which a measurement tool measure what it is intended to measure
predictive value
the extent to whic an observation or test result is able to predict the presence of a given disease or condition
clinical course
evolution of a disease
acute
severe, self limiting
sub acute
intermediate or between acute and chronic- not as prolonged
chronic
continuous long term
subclinical
not clinically apparent
epidemiolgogy
the study of disease occurence in human populations.
how it is spread, how to control, prevent, and eliminate
disease case
either existing case or the number of new episodes of an illness
incidence
the number of new cases arising in a population during a specific time
prevalence
measure of existing disease in a given population at a given point in time
morbitity
the effects an illness has on a persons life. related to incidence, presistance, and long term
mortality
causes of death in a given population
cross sectional study
compare prevalence of disease in those exposed vs unexposed
case control
compares people with outcome of interest and those know not to have the outcome of interest
cohort
group of people who were born around the same time or share characterisitcs
primary prevetion
removing risk factors
secondary prevention
detecting disease early before symptoms
tertiary prevention
clinical interventions that prevent further deterioration or reducing complications of disease
cell changes related to nursing
stroke alert- cells dying need to act quick before they die because its irreversible
atrophy
cells decrease in size in response to decreased work load or adverse environmental conditions
-cell cannot support its metabolic requirements
-cells smaller size is more efficeint
causes of atrophy
disuse (cast), denervation, loss of endrocine stimulation, inadequate nutrition, ischemia or decreased blood flow
hypertrophy
increase in cell size leading to an increase in the amount of functioning tissue mass
-cardiac and skeletal muscle tissues
-increase in functional components of the cells to achieve equilibrium
physiologic hypertrophy!
normal stimuli ex: increase muscle mass from exercise
pathologic hypertrophy!
result of disease conditions
-adaptive or compensatory
hyperplasia
increase in number of cells, only occurring in tissues/organs that are capable of mitotic division (epithelium and glandular)
physiologic hyperplasia
normal.Hormonal or compensatory (liver regeneration)
non physiologic
benign prostatic hyperplasia
metaplasia
replacement of one cell type by another cell type- genetic reprogramming in response to chronic inflammation or irritation -substitution of cells that are better able to survive under circumstances in which a fragile cell type wouldnt
dysplasia
cells varying in size shape and organization- deranged cellular growth in a tissue- ex. cervical dysplasia
intracellular accumulations
buildup of substances that cells canot immediately use or eliminate ex jaundice